Semi-Annual Report — FY2026 H1
What MIZUHO MEDY CO.,LTD. reported for the period from 2026-01-01 to 2026-12-31.
Filed 2026-08-12View the original on EDINET
How much it says
47Typical
What moved here
9named for the first time
Its own wording
18terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the interim accounting period from 1 January 2026 to 30 June 2026, net sales were ¥3,533 million and operating income was ¥996 million. Although shipments of COVID-19 test products declined, sales to hospitals and private practices also decreased due in part to increased demand for combined tests with influenza. Foreign exchange gains of ¥55 million were recorded as non-operating income.
Komori's summary of this document, not the document's own words.47Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
61
Detailed
68
Detailed
42
Thin
75
Very detailed
0
Almost nothing
12
Almost nothing
37
Thin
62
Detailed
60
Detailed
55
Typical
50
Typical
R&D spend4億円Money spent making new things.
Cash left over101億円Cash from the business, less what went into equipment.
Spent on equipment2億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.